Hydroxyzine Pamoate
Product Images NDC 52959-433

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Pamoate (NDC 52959-433). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Formula (644f71c7 C732 472e B750 1a25c93d0ffb 01)

FDA Label Image

Hydroxyzine Pamoate Capsules Usp 25 mg 100s Label (644f71c7 C732 472e B750 1a25c93d0ffb 02)

Hydroxyzine Pamoate Capsules Usp 25 mg 100s Label (644f71c7 C732 472e B750 1a25c93d0ffb 02)
This is a medication description for Hydroxyzine Pamoate in 25mg capsules with Lot #: HYP201YO manufactured by TEVA PHARM. The capsules are yellow and pink with an expiration date of 04/14. The manufacturer's National Drug Code (NDC) is 0555-0323-04, and it's compared to Vistaril. There is a caution statement indicating that medication use is subject to a doctor's prescription only. The text also includes information on dosage and handling.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.